| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
3,554
|
4,101
|
5,761
|
4,210
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
3,554
|
4,101
|
5,761
|
4,210
| |
|
Operating Expenses |
|
Research Development | 7,411 | 11,090 | 12,072 | 12,777 |
|
Selling General and Administrative | 1,382 | 1,929 | 1,591 | 1,609 |
|
Non Recurring | 77 | 1,777 | 114 |
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(5,316)
|
(10,695)
|
(8,016)
|
(10,176)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,990 | 822 | (518) | (940) |
|
Earnings Before Interest And Taxes | (3,326) | (9,873) | (8,534) | (11,116) |
|
Interest Expense | 1,180 | 1,180 | 1,166 | 1,160 |
|
Income Before Tax | (4,506) | (11,053) | (9,700) | (12,276) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (4,506) | (11,053) | (9,700) | (12,276) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(4,506)
|
(11,053)
|
(9,700)
|
(12,276)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(4,506)
|
(11,053)
|
(9,700)
|
(12,276)
|
|
0.02(1.01%) 11:24AM EDT - Nasdaq Real Time Price